A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel

Clinical trial NCT00313456 · TERMINATED

Trial details

NCT number: NCT00313456
Sponsor: Agennix
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Tumors Prostate Cancer

Start date: 2006-03-01
Primary completion: 2009-03-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.